Add BrightSurf on Google Email

Scientists discover how the body's killer cells attack cancer

Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.

SourceUniversity of Southampton·JournalScience Advances·TypeRandomized controlled/clinical trial·DateAug 28, 2024

Pink elephants in the brain?

A study published in Neuron reveals that neurons are wired to connect seemingly unrelated concepts, enhancing the brain's ability to predict what we see based on past experiences. Visual experience influences the organisation of feedback projections, which store information about the world.

SourceChampalimaud Centre for the Unknown·JournalNeuron·TypeExperimental study·DateAug 12, 2024

Pioneering the cellular frontier

Researchers from Brookhaven National Laboratory have developed an effective way to image a single cell using multiple techniques, providing significant implications in medicine and agriculture. The team used advanced X-ray imaging technologies to capture high-resolution images of the cellular structure and chemical processes within cells.

SourceDOE/Brookhaven National Laboratory·JournalNature Communications·TypeImaging analysis·DateJul 23, 2024

Engineered extracellular vesicles enable high-efficient delivery of intracellular therapeutic proteins

Researchers developed an approach to deliver intracellular therapeutic proteins using engineered extracellular vesicles (EVs), bypassing the need for scaffold proteins. This method demonstrated significant activation of interferon signaling and potent antitumor responses in both in vitro and in vivo experiments.

SourceHigher Education Press·JournalProtein & Cell·TypeExperimental study·DateJul 17, 2024

Protein droplets likely don’t cause Parkinson’s

Researchers investigated the relationship between protein aggregation and liquid-liquid phase separation, finding that droplet formation may actually protect against aggregation. The study, led by Paul Scherrer Institute, used over 500 conditions to test the behavior of alpha-synuclein proteins.

SourcePaul Scherrer Institute·JournalAdvanced Science·TypeExperimental study·DateJul 15, 2024

Neuroscience research leverages stem cells to understand how neurons connect and communicate in the brain

Researchers at Colorado State University used human stem cells to study synaptic connections in the brain, focusing on GABAergic synapses. They found that Gephyrin promotes autonomous assembly of these synapses, which can develop independently of neuronal communication. This understanding could lead to new treatments for neurological d...

SourceColorado State University·JournalProceedings of the National Academy of Sciences·DateJun 26, 2024

Changes Upstream: RIPE team uses CRISPR/Cas9 to alter photosynthesis for the first time

Researchers from the University of Illinois have used CRISPR/Cas9 to alter the upstream regulatory DNA of a food crop, increasing gene expression and improving downstream photosynthesis. This approach, which does not require adding foreign DNA, has shown promising results in increasing photosynthetic activity in rice.

Comprehensive transcriptional atlas of human adenomyosis deciphered by the integration of single-cell RNA-sequencing and spatial transcriptomics

A comprehensive transcriptional atlas of human adenomyosis has been created using single-cell RNA-sequencing and spatial transcriptomics. The study reveals unique epithelial and stromal subpopulations and aberrant signaling pathways involved in adenomyosis, supporting both invagination and metaplasia theories.

SourceHigher Education Press·JournalProtein & Cell·TypeExperimental study·DateMay 30, 2024

Fighting cancer with artificial cells

A research team led by Martin Hanczyc is developing artificial cells with specific elements to target cancer cells, aiming to stop their growth and defeat cancer. The team will create bio-hybrid tissues where artificial cells interact with living carcinogenic cells to influence cancer development.

New insights into cholesterol dynamics shed light on neurodegenerative disease

A study published in PNAS reveals the structure of a protein linked to neurodegenerative disease Niemann-Pick type C, which accumulates cholesterol within cellular compartments. The research sheds light on the complex mechanism of cholesterol distribution and its role in maintaining optimal levels.

SourceAarhus University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 3, 2024

Microalgae with unusual cell biology

Researchers studied Prorocentrum cordatum to understand its molecular processes, revealing a unique photosynthetic machinery that may help it adapt to changing light conditions. The findings could lead to improved understanding of harmful algal blooms and their role in climate change.

SourceUniversity of Oldenburg·JournalPLANT PHYSIOLOGY·TypeImaging analysis·DateMar 5, 2024

Drug used for cocaine addiction may pave way for new treatment of advanced colon cancer

A new study from the University of Ottawa proposes using vanoxerine, a drug initially developed for cocaine addiction, to potentially treat advanced colon cancer. Vanoxerine has been found to suppress cancer stem cell activity in colon cancer patients' tissues and tumours implanted in laboratory animals. The drug works by interfering w...

SourceUniversity of Ottawa·JournalNature Cancer·TypeMeta-analysis·DateFeb 13, 2024

Big impacts from small changes in cell

Researchers at Göttingen and Warwick Universities studied the structure and mechanics of cytoskeletal networks composed of actin isoforms. The study found that gamma actin forms rigid networks near the cell apex, while beta actin preferentially forms parallel bundles with distinct organizational patterns.

SourceUniversity of Göttingen·JournalNature Communications·TypeExperimental study·DateDec 22, 2023

Accelerating drug development for lung diseases: New insights from single-cell genomics

A new experimental model, human precision-cut lung slices (hPCLS), was used to study lung disease mechanisms and understand treatment response. The team leveraged single-cell genomics to analyze cell activity in hPCLS after specific treatments.

Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

Researchers discovered distinct mechanisms controlling different types of immune cells and found a way to selectively eliminate 'problematic' cells driving autoimmune disorders. This breakthrough offers precise targets for potential treatment strategies, potentially revolutionizing the way we treat skin conditions.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalScience·TypeExperimental study·DateNov 30, 2023

Cell atlases of the human brain presented in Science

Two parallel projects publish detailed cell atlases of the adult human brain and brain development, revealing over 3,000 cell types, including new insights into brain diseases and potential therapeutic targets. The freely available brain atlases will enable researchers to compare healthy brains with diseased ones.

SourceKarolinska Institutet·JournalScience·TypeExperimental study·DateOct 12, 2023

Red blood cell transfusion in the ICU

Red blood cell transfusions were common in ICU patients globally, with overlapping reasons for use despite differing clinical contexts. The three most common triggers for transfusion (hypotension, tachycardia, hemodynamic instability) were largely consistent across regions.

SourceJAMA Network·JournalJAMA·DateOct 12, 2023

A hygiene program for chromosomes

A new compartment in mammalian cells, the exclusome, has been discovered to house DNA rings that can be ejected from the nucleus. This process helps protect chromosomes from foreign DNA that could disrupt cellular function. The discovery sheds light on a potential link between the exclusome and autoimmune diseases.

SourceETH Zurich·JournalMolecular Biology of the Cell·TypeObservational study·DateOct 2, 2023

Three new articles in the Special Issue “Single-Cell and Spatially Resolved Omics - I” of Journal of Pharmaceutical Analysis Articles describe how single-cell and spatially resolved omics can identify novel therapeutic targets

Researchers have identified novel therapeutic targets using single-cell and spatially resolved omics, including cannabidiol for colorectal tumors, Cux1 as a potential target for dry skin diseases, and microglia communication for Alzheimer's disease. These studies offer hope for future treatments.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateSep 18, 2023

Research led by the US and IBiS identifies a new cell type that is key in the development of memory and learning

Researchers have identified a new cell type, ARG1+ microglia, involved in brain development and function during early postnatal stages. This discovery sheds light on the role of microglia in neural systems and their potential link to neurodevelopmental and neurodegenerative diseases such as Alzheimer's.

SourceUniversity of Seville·JournalNature Neuroscience·TypeObservational study·DateAug 30, 2023

Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial

Imperial researchers have imaged Piezo1 channels in human cells and organs, revealing their role in regulating blood pressure, respiration, bladder control, and the immune system. This breakthrough could lead to a better understanding of their role in fundamental physiological processes and potentially new drug targets for diseases.

SourceImperial College London·JournalNature Communications·TypeExperimental study·DateAug 21, 2023

Cell biology: How cellular powerhouses call for help when under stress

A team of researchers from Goethe University Frankfurt has discovered a central switch point in the mitochondrial signaling chain under misfolding stress. The mitochondria send two chemical signals to the cell when protein misfolding stress occurs, triggering a protective response that reduces misfolded proteins and stabilizes membranes.

SourceGoethe University Frankfurt·JournalNature·TypeExperimental study·DateJul 28, 2023

Team from Korea University medicine explores ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Researchers from Korea University Medicine have discovered a potential therapeutic target for overcoming cisplatin resistance and neuropathic pain in cervical cancer. By inhibiting TRPV1, they found that resistant tumors became vulnerable to cisplatin, improving the outlook for patients.

SourceKorea University College of Medicine·JournalNature Communications·TypeExperimental study·DateJul 20, 2023

Cell-to-cell diversity is key to protecting brain from neurological diseases: University of Ottawa research

A University of Ottawa study reveals that a diverse brain's ecosystem is key to maintaining normal function while responding to changes. This concept is inspired by Charles Darwin's idea that biodiversity is crucial for survival, suggesting cell-to-cell diversity helps prevent failures in brain circuits.

SourceUniversity of Ottawa·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateJul 18, 2023

Are more babies born if embryos are cultured for three or five days in the lab? Largest randomised clinical trial to date suggests that age matters

A large randomized clinical trial found that culturing embryos for three days versus five days in the lab has no significant impact on live birth rates. Women's age affects outcomes, with younger women aged under 36 experiencing better results from cleavage-stage transfers.

SourceEuropean Society of Human Reproduction and Embryology·TypeRandomized controlled/clinical trial·DateJun 26, 2023

Researchers urge caution in gene editing early human embryos following findings that it could have unexpected and dangerous consequences Further research to refine gene editing technology is needed

Researchers have discovered that gene editing technologies may introduce unintended mutations and damage to DNA in early human embryos. The study found that most cells repair breaks in the DNA using non-homologous end joining, which can lead to additional genetic abnormalities.